endocrine therapy - Robuta Search

https://www.emjreviews.com/oncology/news/almost-20-of-breast-cancer-patients-fail-to-complete-prescribed-endocrine-therapy/ Almost 20% of Breast Cancer Patients Fail to Complete Prescribed Endocrine Therapy - European... Dec 14, 2016 - Lugano-Singapore, December 14, 2016 – Around 20% of breast cancer patients do not complete prescribed endocrine therapy, researchers report at the ESMO... breast cancer endocrine therapy almost patients fail https://www.themednet.org/would-you-consider-a-cdk-4-6-inhibitor-in-combination-with-endocrine-therapy-for-a-patient-with-er-low-1-9-metastatic-breast-cancer Would you consider a CDK 4/6 inhibitor in combination with endocrine therapy for a patient with ER... Physician discussion: Would you consider a CDK 4/6 inhibitor in combination with endocrine therapy for a patient with ER low (1-9%) metastatic breast cancer?.... would you endocrine therapy for patient consider cdk https://unige.iris.cineca.it/handle/11567/1121156 The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy... the association endocrine therapy adiposity anti proliferative https://www.researchtoactionforum.org/2018/10/31/endocrine-therapy-has-historically-shaped-the-foundation-of-treatment-of-metastatic/ Endocrine therapy has historically shaped the foundation of treatment of metastatic – Selective and... endocrine therapy historically shaped foundation treatment https://rdrmn.com/document/stein-hormone-blocking-endocrine-therapy-2-5-2025/ Stein CME - Hormone Blocking: Endocrine Therapy 2.5.2025 - Regional Diagnostic Radiology : Regional... endocrine therapy diagnostic radiology stein cme hormone https://www.cgtlive.com/view/adjuvant-endocrine-therapy-breast-cancer-longer-therapy-and-need-personalized-treatmentshould-we Adjuvant Endocrine Therapy for Breast Cancer: Longer Therapy and the Need for Personalized... Oct 15, 2026 - In the future, we also need to improve our ability to personalize the duration of endocrine therapy, with a goal of optimizing patient selection for extended... endocrine therapy breast cancer adjuvant longer need https://instituteofmineralresearch.org/therapy-of-endocrine-disease-impact-of-iodine-supplementation-in-mild-to-moderate-iodine-deficiency-systematic-review-and-meta-analysis/ Therapy of endocrine disease: Impact of iodine supplementation in mild-to-moderate iodine... endocrine disease therapy impact iodine supplementation https://www.cancernetwork.com/view/commentary-lipton-current-status-endocrine-therapy-metastatic-breast-cancer Commentary (Lipton): Current Status of Endocrine Therapy for Metastatic Breast Cancer |... Oct 9, 2026 - This year approximately 200,000 new cases of breast cancer will be diagnosed in the United States. Primary surgical treatment plus adjuvant therapy will cure... metastatic breast cancer current status endocrine therapy commentary lipton https://ascopost.com/news/march-2025/palbociclib-plus-endocrine-therapy-vs-capecitabine-in-hr-positive-her2-negative-metastatic-breast-cancer/ Palbociclib Plus Endocrine Therapy vs Capecitabine in HR-Positive, HER2-Negative Metastatic Breast... In an overall survival analysis of a South Korean phase II trial (Young-PEARL) reported in The Lancet Oncology, Ahn et al found no benefit with palbociclib... endocrine therapy palbociclib plus capecitabine positive https://experts.umn.edu/en/projects/a-phase-2-study-of-alisertib-in-combination-with-endocrine-therap/ A PHASE 2 STUDY OF ALISERTIB IN COMBINATION WITH ENDOCRINE THERAPY IN PATIENTS WITH HR+,... endocrine therapy phase study alisertib combination https://diposit.ub.edu/items/e4e6f0a9-290c-4017-8ee8-1b2688b4b34b VAV3 mediates resistance to breast cancer endocrine therapy Endocrine therapies targeting cell proliferation and survival mediated by estrogen receptor α (ERα) are among the most effective systemic treatments for... breast cancer endocrine therapy mediates resistance https://xuebao.shsmu.edu.cn/EN/Y2025/V45/I2/194 Best evidence summary of weight management in patients undergoing endocrine therapy for prostate... Objective ·To retrieve and evaluate evidence related to weight managem... best evidence weight management endocrine therapy summary patients https://agendia.com/less-single-arm-study-to-de-escalate-adjuvant-endocrine-therapy-duration-in-post-menopausal-women-with-hr-her2-breast-cancer-at-very-low-risk-of-metastasis/ LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women... Feb 16, 2024 - Publication: ASCO 2023, Abstract TPS615 Authors: Elise Deluche, Stefan Michiels, Daniele Fric, Christophe Perrin, Caroline Bailleux, Thomas Bachelot, Pascal Ko... endocrine therapy post menopausal less single arm https://www.mdpi.com/2072-6694/17/21/3538 CDK4/6 Inhibitors Plus Endocrine Therapy in Early-Stage HR+/HER2− Breast Cancer: Updated... Background/Objectives: This meta-analysis aimed to evaluate the efficacy of combining CDK4/6i with ET, compared with ET alone, in improving invasive... endocrine therapy early stage breast cancer inhibitors plus